midazolam viatris
viatris limited - midazolam 1 mg/ml; - solution for injection - 1 mg/ml - active: midazolam 1 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).
neostigmine methylsulphate
astrazeneca limited - neostigmine metilsulfate 0.5 mg/ml - solution for injection - 0.5 mg/ml - active: neostigmine metilsulfate 0.5 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate sodium chloride water for injection
neostigmine methylsulphate
juno pharmaceuticals nz limited - neostigmine metilsulfate 2.5 mg/ml - solution for injection - 2.5 mg/ml - active: neostigmine metilsulfate 2.5 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - · reversal of the effects of nondepolarising neuromuscular blocking agents (e.g. tubocurarine, pancuronium etc.).
oxytocin injection bp
boucher & muir (new zealand) limited t/a bnm group - oxytocin 10 iu/ml equivalent to 16.6 mcg/ml; - solution for injection - 10 iu/ml - active: oxytocin 10 iu/ml equivalent to 16.6 mcg/ml excipient: glacial acetic acid sodium acetate sodium chloride water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · oxytocin injection bp may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion. postpartum: · during caesarean section, after the delivery of the child. · prevention and treatment of postpartum uterine atony and haemorrhage.
oxytocin injection bp
boucher & muir (new zealand) limited t/a bnm group - oxytocin 5 iu/ml equivalent to 8.3 mcg/ml; - solution for injection - 5 iu/ml - active: oxytocin 5 iu/ml equivalent to 8.3 mcg/ml excipient: glacial acetic acid sodium acetate sodium chloride water for injection - antepartum: · induction of labour for medical reasons, e.g. in cases of post-term gestation, premature rupture of the membranes, pregnancy-induced hypertension (pre-eclampsia). · enhancement of labour in selected cases of uterine inertia. · oxytocin injection bp may also be indicated in early stage of pregnancy, as adjunctive therapy for management of incomplete, inevitable or missed abortion. postpartum: · during caesarean section, after the delivery of the child. · prevention and treatment of postpartum uterine atony and haemorrhage.
septanest
ivoclar vivadent ltd - adrenaline acid tartrate 10 µg/ml; ; ; articaine hydrochloride 40 mg/ml; - solution for injection - 40mg/10µg per ml - active: adrenaline acid tartrate 10 µg/ml articaine hydrochloride 40 mg/ml excipient: sodium chloride sodium hydroxide sodium metabisulfite water for injection - septanest 1:100,000 is indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. septanest 1:100,000 is indicated only for dental procedures.
midazolam-baxter
baxter healthcare ltd - midazolam 5 mg/ml - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml excipient: hydrochloric acid hydrochloric acid (ph adjuster) sodium chloride sodium hydroxide water for injection - premedication before induction of anaesthesia (i.m. or, especially in children, rectal, intranasal or oral administration).
neostigmine methylsulfate injection
max health limited - neostigmine metilsulfate 2.5 mg/ml - solution for injection - 2.5 mg/ml - active: neostigmine metilsulfate 2.5 mg/ml excipient: nitrogen sodium chloride water for injection - · propylaxis and treatment of post-operative intestinal atony and urinary retention.
noradrenaline bnm noradrenaline (as acid tartrate monohydrate) 1mg/1ml injection concentrated ampoule
boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 2 mg/ml (equivalent: noradrenaline (norepinephrine), qty 1 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.
b. braun midazolam midazolam (as hydrochloride) 5 mg/1 ml solution for injection ampoule
b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.